ScanSource Reaffirms Its FY25 Guidance: Sees Net Sales Of $3.1B–$3.5B Vs. $3.439B Est.; Adjusted EBITDA Of $140M–$160M, And Free Cash Flow Of At Least $70M

Benzinga
01-30

Annual Financial Outlook for Fiscal Year 2025

ScanSource reaffirms previously provided guidance set forth below for the full fiscal year ended June 30, 2025.

  FY25 Annual Outlook 
Net sales $3.1 billion to $3.5 billion 
Adjusted EBITDA (non-GAAP) $140 million to $160 million 
Free cash flow (non-GAAP) At least $70 million 

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10